Saudi Arabia SFDA Registration Medical Devices

Our regulatory consulting specialists support regulatory compliance with the SFDA
 
Saudi Food and Drug Authority
.

SDFA registration medical devices

In Saudi Arabia, the regulatory submission process for medical devices is overseen by the Saudi Food and Drug Authority (SFDA). The applicable regulation is the Medical Devices and Supplies Regulation, Council of Ministers’ Resolution No. 337 (Medical Devices Law) which outlines the requirements for the registration and approval of medical devices in the country and replaced  the Medical Devices Interim Regulation. The Implementing Regulation of the Law of Medical Devices was issued in 2021 and it reinforces the medical device regulatory framework set out in the Medical Devices Law and discusses the provisions of the Law in greater detail, including the required content of the Technical File. 

Medical Devices Law and its Implementing Regulation show significant overlap with the requirements of the European EU MDR and EU IVDR in its approach to review but also in terms of the required set of documents being part of the technical documentation.

GO-TO-MARKET STRATEGY AND REGISTRATION SUPPORT

Do you need assistance with your strategy for the SFDA medical device regulations? 

 

Contact us

https://www.qservegroup.com/write/Afbeeldingen1/05. Market Access/520-250-Saudi-Arabie-2.jpg?preset=content

Medical Device Classification in Saudi Arabia

Risk-based classification

Medical devices in Saudi Arabia are classified based on the level of risk associated with their use. The classification system mirrors international standards and is divided into four classes (class A can be further divided into 2 groups):

  • Class A: Low-risk devices (e.g., non-sterile, non-measuring instruments)
  • Class A: Low to medium risk devices (e.g., supplied sterile, incorporating a measuring function or reusable surgical instruments)
  • Class B: Low to medium risk devices 
  • Class C: Medium to high-risk devices
  • Class D: High-risk devices

IVD Medical Devices are classified as follows:

  • Class A: Low Individual Risk and Low Public Health Risk
  • Class B: Moderate Individual Risk and/or Low Public Health Risk
  • Class C: High Individual Risk and/or Moderate Public Health Risk
  • Class D: High Individual Risk and High Public Health Risk

This classification helps in determining the regulatory requirements and the level of scrutiny a device must undergo before it can be marketed in Saudi Arabia.

Medical Device Approval Saudi Arabia

SFDA registration medical devices

To market a medical device in Saudi Arabia, manufacturers must obtain approval from the SFDA. The approval process involves several steps:

  • Compliance with Essential Principles: Devices must comply with the Essential Principles of Safety and Performance specified by the SFDA.
  • Technical Documentation: Preparation and maintenance of comprehensive technical documentation are required to demonstrate compliance with these principles.
  • Quality Management System: Manufacturers must establish and maintain a Quality Management System (QMS) in accordance with ISO 13485:2016 or an equivalent standard.
  • Application Submission: Applications for Medical Devices Marketing Authorization (MDMA) must be submitted electronically through the SFDA's E-Services portal.
  • Fees and Review: Payment of applicable fees and review of submitted documentation by the SFDA.
  • Issuance of MDMA: Upon satisfactory review, the SFDA issues the MDMA, allowing the device to be marketed in Saudi Arabia.
 

Medical devices and IVD registration

We offer comprehensive support for registration and license holding service in KSA. When reaching out for a quote, kindly provide information on the devices under consideration and their respective risk classifications. We require documents such as IFUs, DoCs, CE certificates, and QMS certificates. Typically, products sharing the same risk class and intended use can be grouped under a single MDMA application, facilitating the process. Factors such as a common legal manufacturer, design, manufacturing process, and a reasonable number of products can streamline this consolidation. Specifically, if the products meet the following criteria:

  • Same legal manufacturer
  • Same intended use
  • Same risk class
  • Same design and manufacturing process
  • Total products do not exceed 50
  • Total technical files do not exceed 5 per application

They can be consolidated within one MDMA application.

CONTACT US

 

Qserve services for Saudi Arabia

  • Regulatory Strategy: Advising on the best approach to comply with Saudi Arabian regulations, including registration and licensing requirements.
  • Registration Support: Assisting with the preparation and submission of documentation required for product registration in Saudi Arabia.
  • Quality Management System (QMS) Implementation: Helping companies establish or enhance their QMS to meet Saudi Arabian regulatory standards.
  • Training and Workshops: Providing education and training sessions on regulatory requirements and compliance best practices specific to Saudi Arabia.
  • Post-Market Surveillance: Supporting companies in fulfilling their post-market obligations, including adverse event reporting and product recalls.
  • Local Representation: Acting as a local representative for foreign medical device companies without a physical presence in Saudi Arabia.

Qserve knows the essential requirements to ensure how to achieve regulatory compliance.  

 
Go-to-market strategy

In terms of resemblance to other regulatory frameworks, the Saudi Arabian system shares similarities with the EU concerning technical documentation and conformity assessment. This alignment facilitates the adaptation of existing documentation from EU compliance standards to meet Saudi Arabian regulatory requirements. Contact us to determine the extent to which your current documentation can be utilized to initiate the process of achieving regulatory compliance in Saudi Arabia. 

Regulatory timelines and fees

The SFDA has established specific timelines for the review and approval of medical devices. These timelines are designed to ensure a rigorous yet efficient review process:

  • Initial Submission Review: Typically, the SFDA reviews initial submissions within 30 to 60 days.
  • Technical Documentation Review: Detailed review of technical documentation can take an additional 60 to 120 days, depending on the complexity of the device.
  • Approval and Issuance of MDMA: The total time from submission to the issuance of MDMA can range from 3 to 6 months.

These timelines can vary based on the completeness of the submission and the need for any additional information or clarification from the manufacturer.